Aug. 10 at 11:00 PM
$DCTH If you break it all down with Gerrard boosting the guidance and showingthe following results 1)
$7.5 million new money in bank 2) funding close to
$10 million in R&D with cashflow without depleting reserves 3) new products in pipeline and without even any increase in revenue this would produce
$60 million profit a year if you put the R&D in the equation without any increase in sales. But this thing is cooking and more to come. If the third quarter even stays steady without any pullbacks you could see a new base well above
$20 and growing. The analyst target of
$32 will be conservative.
